Introducing a nationwide registry: The Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS)

Acta Neurochirurgica

Volumn 154, Issue 12, 2012, Pages 2173-2178

  Schatlo, Bawarjan ^a   Fung, Christian ^b   Fathi, Ali Reza ^c   Sailer, Martin ^d   Winkler, Kerstin ^e   Daniel, Roy Thomas ^f   Bijlenga, Philippe ^a   Ahlborn, Peter ^c   Seule, Martin ^c   Zumofen, Daniel ^d   Reinert, Michael ^b   Woernle, Christoph ^e   Stienen, Martin ^c   Levivier, Marc ^f   Hildebrandt, Gerhard ^c   Mariani, Luigi ^d   Bernays, René ^e   Fandino, Javier ^c   Raabe, Andreas ^b   Keller, Emanuela ^e   Schaller, Karl ^a   more..

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Kantonsspital Aarau ^*  (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cerebral aneurysm; Intracranial aneurysm; Subarachnoid haemorrhage

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DATA BASE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FUNDING; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL STATUS; STANDARDIZATION; SUBARACHNOID HEMORRHAGE; SWITZERLAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; REGISTRIES; SUBARACHNOID HEMORRHAGE; SWITZERLAND; YOUNG ADULT;

EID: 84871039516     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-012-1500-4     Document Type: Article

References (21)

1. Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS (2003) In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery 52: 995-1007, discussion 1007-1009
2. Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38: 330-336
3. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78: 1365-1372
4. Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Muller I, Klockgether T, Schramm J, Urbach H, Meyer B (2010) Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke41: 2918-2923
5. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3): CD000277
6. Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17: 439-447
7. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9
8. Graff-Radford NR, Torner J, Adams HP Jr, Kassell NF (1989) Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 46: 744-752
9. Hemphill JC, Andrews P, De Georgia M (2011) Multimodal monitoring and neurocritical care bioinformatics. Nat Rev Neurol 7: 451-460
10. Jaeger M, Soehle M, Schuhmann MU, Winkler D, Meixensberger J (2005) Correlation of continuously monitored regional cerebral blood flow and brain tissue oxygen. Acta Neurochir (Wien) 147: 51-56, discussion 56
11. Johnston SC, Selvin S, Gress DR (1998) The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 50: 1413-1418
12. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10: 618-625
13. Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 3: 256-263
14. Maud A, Lakshminarayan K, Suri MF, Vazquez G, Lanzino G, Qureshi AI (2009) Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg 110: 880-886
15. Meyer B, Ringel F, Winter Y, Spottke A, Gharevi N, Dams J, Balzer-Geldsetzer M, Mueller IK, Klockgether T, Schramm J, Urbach H, Dodel R (2010) Health-related quality of life in patients with subarachnoid haemorrhage. Cerebrovasc Dis 30: 423-431
16. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF (2005) Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36: 992-997
17. Rosen DS, Macdonald RL (2005) Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care 2: 110-118
18. Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA (1997) Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences. J Neurosurg 86: 583-588
19. Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P (2003) Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 98: 1227-1234
20. Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15: 573-585
21. Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, Newell D, Verweij B, Bullock MR, Baker A, Coplin W, Mericle R, Dai J, Rocke D, Muizelaar JP (2008) Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke; J Cereb Circ 39: 1759-1765